Roadmap to resuming care for liver diseases after coronavirus disease-2019

the Global Online Alliance for Liver Studies (GOAL)

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

The global pandemic of coronavirus disease-2019 (COVID-19) has led to significant disruptions in healthcare delivery. Patients with chronic liver diseases require a high level of care and are therefore particularly vulnerable to disruptions in medical services during COVID-19. Recent data have also identified chronic liver disease as an independent risk factor for COVID-19 related hospital mortality. In response to the pandemic, national and international societies have recommended interim changes to the management of patients with liver diseases. These modifications included the implementation of telehealth, postponement or cancelation of elective procedures, and other non-urgent patient care-related activities. There is concern that reduced access to diagnosis and treatment can also lead to increased morbidity in patients with liver diseases and we may witness a delayed surge of hospitalizations related to decompensated liver disease after the COVID-19 pandemic has receded. Therefore, it is paramount that liver practices craft a comprehensive plan for safe resumption of clinical operations while minimizing the risk of exposure to patients and health-care professionals. Here, we provide a broad roadmap for how to safely resume care for patients with chronic liver disease according to various phases of the pandemic with particular emphasis on outpatient care, liver transplantation, liver cancer care, and endoscopy.

Original languageEnglish
Pages (from-to)885-892
Number of pages8
JournalJournal of Gastroenterology and Hepatology (Australia)
Volume36
Issue number4
DOIs
StatePublished - Apr 2021

Keywords

  • COVID-19
  • Chronic liver disease
  • Endoscopy
  • Hepatocellular carcinoma
  • Hepatology
  • Liver transplantation
  • Outpatient
  • Post-pandemic
  • SARS-CoV-2

Fingerprint

Dive into the research topics of 'Roadmap to resuming care for liver diseases after coronavirus disease-2019'. Together they form a unique fingerprint.

Cite this